Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ANIXA BIOSCIENCES INC (ANIX) vs ImmuCell Corporation (ICCC)

ANIXA BIOSCIENCES INC and ImmuCell Corporation are both Biotechnology companies. ANIXA BIOSCIENCES INC and ImmuCell Corporation are of similar size ($96.6M and $90.6M). ANIXA BIOSCIENCES INC has negative trailing earnings, so its P/E is not meaningful; ImmuCell Corporation trades at 117×. ImmuCell Corporation grew revenue faster over the last twelve months: 8.49% against −34.1%. ImmuCell Corporation has the higher net margin (2.57% vs 0.00%) and the higher return on invested capital (7.84% vs 0.00%). Across the 18 metrics below, ImmuCell Corporation leads on 16 and ANIXA BIOSCIENCES INC on 2.

Valuation

Metric ANIX ICCC Biotechnology median
P/E n/m 117.38 7.88
P/S 97.76 2.93 11.47
P/B 7.20 2.87 2.52
Price to free cash flow n/m 21.27 21.16
EV/EBITDA n/m 14.22 0.74
EV/Sales 85.36 2.92 10.73
Earnings yield (11.51%) 0.85% (28.84%)
Free cash flow yield (7.73%) 4.70% (23.03%)

Profitability

Metric ANIX ICCC Biotechnology median
Gross margin 0.00% 40.32% 65.16%
Operating margin 0.00% 12.60% 0.00%
Net margin 0.00% 2.57% 0.00%
Free cash flow margin 0.00% 13.79% 0.00%
Return on equity (72.57%) 2.57% (57.72%)
Return on assets (63.45%) 1.69% (49.22%)
Return on invested capital 0.00% 7.84% 0.00%

Growth

Metric ANIX ICCC Biotechnology median
Revenue growth (TTM) (34.10%) 8.49% 5.64%
EPS growth (last fiscal year) 12.82% 53.85% —
Revenue growth, 5-year CAGR (6.89%) 12.50% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANIX ICCC Biotechnology median
Debt to equity 0.00 0.26 0.00
Current ratio 8.55 4.75 4.73
Net debt to EBITDA 1.29 1.19 0.96

Dividend

Metric ANIX ICCC Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ANIX ICCC Biotechnology median
Market cap 96.64m 90.55m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack